# EDGAR Filing Document

**Accession Number:** 0002137132
**File Stem:** 0002137132-26-000002
**Filing Date:** 2026-6
**Character Count:** 9963
**Document Hash:** 49405383dd17b0b943aca3e3cae20170
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002137132-26-000002.hdr.sgml**: 20260604

**ACCESSION NUMBER**: 0002137132-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260601

**FILED AS OF DATE**: 20260604

**DATE AS OF CHANGE**: 20260604

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Hansman Brad W.
- **CENTRAL INDEX KEY:** 0002137132

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37856
- **FILM NUMBER:** 261065649

**MAIL ADDRESS:**
- **STREET 1:** 5375 MEDPACE WAY
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45227
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medpace Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001668397
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 320434904
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5375 MEDPACE WAY
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45227
- **BUSINESS PHONE:** (513) 579-9911

**MAIL ADDRESS:**
- **STREET 1:** 5375 MEDPACE WAY
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45227

## Ex-24

![](hansmanpoa001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;POWER OF ATTORNEY The undersigned hereby makes, constitutes and appoints each of Anne Eisele, Stephen P. Ewald, Allison A Westfall, Christopher T. Colloton and F. Mark Reuter, and with full power of substitution, re- substitution and delegation, the undersigned's true and lawful attorney-in-fact (such person their substitutes and delegees being referred to herein as the "Attorney-in-Fact"), with full power to act for the undersigned and in the undersigned's name, place and stead, in the undersigned's capacity as an officer, director or stockholder of Medpace Holdings, Inc. (the "Company"), to: 1. Take such actions as may be necessary or appropriate to enable the undersigned and/or the Company to submit and file forms, schedules and other documents with the U.S. Securities and Exchange Commission ("SEC") utilizing the SEC's Electronic Data Gathering and Retrieval ("EDGAR") system, which actions may include (a) enrolling the undersigned and/or the Company in EDGAR Next and (b) preparing, executing and submitting to the SEC a Form ID, amendments thereto, and such other documents and information as may be necessary or appropriate to obtain codes and passwords enabling the undersigned and/or the Company to make filings and submissions utilizing the EDGAR system; 2. Act as an account administrator for the undersigned's and/or the Company's EDGAR account, including: (i) appoint, remove and replace account administrators, account users, technical administrators and delegated entities; (ii) maintain the security of the undersigned's EDGAR account, including modification of access codes; (iii) maintain, modify and certify the accuracy of information on the undersigned's EDGAR account dashboard; (iv) act as the EDGAR point of contact with respect to the undersigned's EDGAR account; and (v) any other actions contemplated by Rule 10 of Regulation S-T with respect to account administrators; and 3. Cause the Company to accept a delegation of authority from any of the undersigned's EDGAR account administrators and, pursuant to that delegation, authorize the Company's EDGAR account administrators to appoint, remove or replace users for the undersigned's EDGAR account. The undersigned acknowledges that: a) This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information; b) Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned and/or the Company pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable; c) Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with securities laws; and d) This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under securities laws. The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing requisite, necessary or advisable to be done in connection with the foregoing, as fully, to all intents and purposes, as the undersigned might or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by authority of this Power of Attorney.

------

![](hansmanpoa002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Power of Attorney shall remain in full force and effect until the Attorney-in-Fact is no longer an account administrator for the undersigned's and/or the Company's EDGAR account, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact. This Power of Attorney revokes all previous powers of attorney with respect to the subject matter of this Power of Attorney. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of _________, 2026 Signature Print Name NOTARIZATION State of _________________ County of _______________ This Power of Attorney was acknowledged before me on [DATE] ________________________ by [NAME] ________________________. ________________________________________________ Notary Signature [Notary Seal] 15635725.v1 Elizabeth Bossart 05/26/2026 10:34 AM EDT Online Notary Public. This notarial act involved the use of online audio/video communication technology. Notarization facilitated by SIGNiX® Ohio Commission Number: 2024-RE-881695 My Commission Expires: 09-11-2029 Elizabeth Bossart May 26 Ohio Hamilton Brad W. Hansman 05/26/2026 10:32 AM EDT Brad W. Hansman

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Hansman Brad W.<br><sub>(Last) (First) (Middle)</sub><br>C/O MEDPACE HOLDINGS, INC.<br>5375 MEDPACE WAY<br><sub>(Street)</sub><br>CINCINNATI, OH 45227<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Medpace Holdings, Inc. [ MEDP ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-06-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Exec. VP, Operations_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 697 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 500 | <sup>(2)</sup> | D |  |
| Restricted Stock Unit | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 5000 | <sup>(2)</sup> | D |  |
| Employee Stock Option (Right to Buy) | <sup>(4)</sup> | 2033-04-24 | Common Stock | 10000 | $410.54 | D |  |

---

### Footnotes:

(1) The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

(2) Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

(3) The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

(4) The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

**Remarks:**
Exhibit List: Exhibit 24 - Power of Attorney

**Signature:** /s/ Stephen P. Ewald, Attorney-in-Fact for Brad W. Hansman  
**Date:** 2026-06-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**